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ABSTRACT Chlamydia trachomatis is the most common sexually transmitted bacte-
rial pathogen worldwide, and there is a need to control this epidemic. So far there is
no established animal model in which both the horizontal and the vertical transmis-
sion of Chlamydia can be studied. To implement a horizontal sexual transmission
model, male mice were inoculated in the meatus urethra with Chlamydia muridarum
and they were caged with naive female mice. Urine and vaginal swab specimens
were collected for culture. To study vertical transmission, newborns were euthanized
and specimens were cultured. As controls, females were mated with sham-infected
male mice. All C. muridarum-inoculated male mice had positive urine cultures. As de-
termined by serology, all females caged with C. muridarum-inoculated males became
infected, and 93% of them had positive vaginal swab specimen cultures. More fe-
males mated with C. muridarum-infected male mice (35%) than females mated with
sham-infected male mice (0%) were infertile (P 0.05). Also, C. muridarum-infected
females delivered signiﬁcantly fewer pups (3.8 3.2/mouse) than control females
(6.3 1.6/mouse) (P 0.05). Of the newborn mice, 32% were C. muridarum positive
either in the lungs or in the intestines. Female mice housed with sham-infected
males had no positive vaginal swab specimen cultures or C. muridarum-positive
pups. This new mouse model of horizontal and vertical sexual transmission of Chla-
mydia closely parallels C. trachomatis sexual transmission in humans and may be a
good model system to better understand the pathogenesis of these infections.
KEYWORDS Chlamydia muridarum, Chlamydia trachomatis, genital infection,
infertility, mouse model, neonatal infection, sexual transmission
Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen,annually infecting approximately 130 million individuals worldwide (1–3). Depend-
ing on the population, about 5% to 20% of women and 4% to 12% of men are positive
for C. trachomatis during their reproductive age (2, 4, 5). In the United States, infections
with C. trachomatis are the most commonly reported to the CDC and affect1.7 million
patients, including 100,000 pregnant women, each year (4, 6). Cervicitis/urethritis in
females and urethritis in males are the most common acute presentations (7). Severe
acute and chronic infections may result in long-term sequelae, including pelvic inﬂam-
matory disease (PID), chronic abdominal pain, ectopic pregnancy, and infertility (8–11).
If C. trachomatis infections during pregnancy are not diagnosed and properly treated,
they can affect 70% of newborns, resulting in conjunctivitis, pneumonia, and gastro-
intestinal colonization (12, 13). Other associated complications include low birth
weight, premature birth, premature rupture of membranes, and an increased risk of
death (14, 15). Since 50% to 80% of infections are asymptomatic, it is difﬁcult to identify
and treat patients (10, 16). Attempts to control chlamydial infections using screening
programs and antibiotic treatment have failed, and there is no licensed vaccine (17–19).
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Pathogen survival depends on the ability to spread from one host to another. Thus,
an effective way to eradicate an infection is to block transmission. Currently, there are
no C. trachomatis sexual transmission models in mice. To study chlamydial infections in
female mice, animals are inoculated by the vaginal, transcervical, uterine, or intrabursal
route (20–25). Rank et al. (26) implemented a model in which male guinea pigs were
infected in the meatus urethra with Chlamydia caviae and were then caged with naive
female guinea pigs. Transmission of C. caviae from male to female guinea pigs was
characterized, but transmission to their newborns was not reported. Guinea pigs have
certain advantages over mice since their estrous cycle is longer (14 versus 5 days)
and the anatomy of their genital tract better resembles that of humans. However, the
longer gestational period of guinea pigs (63 to 68 versus 21 days for mice), the lack
of immunological reagents for in-depth analyses, and the high cost of purchase and
maintenance of guinea pigs discourage the use of the guinea pig model. The numerous
immunological tools, harem-style breeding, and lower maintenance costs make mice
an attractive alternative model for analyzing C. trachomatis sexual transmission.
The goal of this study was to implement a new mouse model of horizontal and
vertical sexual Chlamydia transmission. Male mice, infected in the meatus urethra with
Chlamydia muridarum, were caged with naive females to analyze horizontal transmis-
sion. To study vertical transmission, pregnant females were followed until delivery and
their newborns were euthanized at 10 postnatal days (PND). This new model can be
used to better understand the immunopathogenesis of these infections and to improve
diagnostic, preventative, and therapeutic measures.
RESULTS
Characterization of C. muridarum infection and humoral immune responses in
male mice. Ten male mice were inoculated with C. muridarum in the meatus urethra.
As controls, 5 male mice were sham infected with sugar phosphate glutamate buffer
(SPG) (Fig. 1A and Table 1). At 1 day after infection, each male mouse was housed with
four naive females for 3 weeks. All male mice were euthanized at 3 weeks postmating.
All 10 inoculated male mice were culture positive for C. muridarum from 4 to 21
postmating days (PMD). The highest number of C. muridarum inclusion-forming units
(IFU) was recovered between 7 and 11 PMD (median, 1.0 106 IFU/ml urine). By 21
PMD, the cumulative median number of C. muridarum IFU recovered per mouse was
2,589,520 (range, 353,340 to 22,746,860). When male mice were euthanized at 22 PMD,
the urethra and urinary bladder were cultured for C. muridarum. All urethrae (10/10)
and 70% (7/10) of the urinary bladders were positive. All infected males developed high
C. muridarum-speciﬁc IgG antibody titers in serum (geometric mean titer [GMT], 11,143;
titer range, 6,400 to 12,800) (Table 2). None of the sham-infected males had positive
urine cultures or C. muridarum-speciﬁc antibody titers.
Assessment of C. muridarum infection in female mice following horizontal
sexual transmission. To study horizontal sexual transmission, 40 naive female mice
were caged with C. muridarum-inoculated males (at a ratio of 4 females to 1 male). As
controls, 20 naive female mice were housed with sham-infected males (at a ratio of 4
females to 1 male). To monitor infection, vaginal swab specimens were collected from
4 to 46 PMD. Over the observation period, 93% (37/40) of the female mice had at least
one positive result by culture of a vaginal swab specimen (Fig. 1B). The median time of
shedding for infected females was 42 PMD (range, 2 to 46 PMD), and the highest rate
of vaginal swab specimen culture positivity (53%) was at 21 PMD. Of the C. muridarum-
positive female mice, 27% (10/37) shed high numbers of C. muridarum IFU (1,000 total
C. muridarum IFU shed in 6 weeks), while 73% (27/37) shed low numbers of IFU (1,000
total C. muridarum IFU shed in 6 weeks). For the high-shedding group, at 6 weeks the
cumulative median number of C. muridarum IFU per mouse was 3,289,572 (range, 4,252
to 16,685,047), while for the low-shedding group, the number was 24 (range, 2 to 134).
None of the female controls caged with sham-infected male mice had positive culture
results for C. muridarum.
Pal et al. Infection and Immunity
July 2019 Volume 87 Issue 7 e00834-18 iai.asm.org 2
 o
n
 N
ovem
ber 27, 2019 at UNIV O
F CALIFO
RNIA IRVINE
http://iai.asm
.org/
D
ow
nloaded from
 
Humoral and cellular immune responses in female mice following C. muri-
darum horizontal infection. At 65 PMD, female mice were euthanized and humoral
and cell-mediated immune (CMI) responses were determined (Tables 2 and 3). All
females housed with infected male mice developed high C. muridarum IgG antibody
titers (GMT, 23,072; range, 3,200 to 102,400), while those caged with sham-infected
males were negative for C. muridarum IgG. Also, in contrast to females mated with
sham-infected male mice, sexually infected females developed high C. muridarum-
speciﬁc T-cell lymphoproliferative responses (change in the counts per minute,
8,283 2,783 versus 562 240; P 0.05). The levels of gamma interferon (IFN-) and
interleukin-17 (IL-17) in the T-cell supernatants were also signiﬁcantly higher in C.
muridarum-infected females than in noninfected females (5,578 148 versus 15 pg/
ml, respectively, for IFN- and 195 33 versus 4 pg/ml, respectively, for IL-17)
(P 0.05). None of the animals had detectable levels of IL-4 (4 pg/ml).
Western blot analysis of control and C. muridarum-infected female, male, and
newborn mice. Western blot analyses were performed with serum samples collected
FIG 1 (A) Number of C. muridarum (Cm) IFU recovered from male mouse urine. Urine samples for culture
were collected from male mice during the 3 weeks of mating. Each continuous thin line corresponds to
a C. muridarum-inoculated male mouse, while the thick line represents the median number of IFU
recovered. Dotted lines denote the limit of detection (LOD; 20 IFU/ml of urine). All sham-inoculated
male mice were negative. (B) Number of C. muridarum IFU recovered from vaginal swab specimen
cultures. Naive female mice were mated with C. muridarum-inoculated male mice, and vaginal swab
specimens for culture were collected over a 6-week period. Each closed circle represents one female
mouse. The numbers at the top indicate the percentages of mice with positive vaginal swab specimen
cultures. The cumulative percentage of positive mice and the number of IFU recovered per mouse are
denoted by closed triangles. All cultures of specimens from females mated with sham-infected males
were negative (not shown). The dotted horizontal line represents the LOD (2 IFU/culture).
Chlamydia Sexual Transmission in Mice Infection and Immunity
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from C. muridarum-infected male, female, and newborn mice (Fig. 2). Sera from
sham-infected mice were used as controls. Sera from infected male, female, and
newborn mice had similar antibody responses, recognizing lipopolysaccharide (LPS;
10 kDa), a 23-kDa band, the major outer membrane protein (MOMP; 42 kDa), the
60 kDa-cysteine-rich protein and/or the 60-kDa heat shock protein, the 70-kDa heat
shock protein, and several high-molecular-mass proteins (100 to 150 kDa), likely corre-
sponding to the polymorphic membrane proteins. As expected, sera from newborn
mice reacted weakly, showing reactivity at the same bands as the mothers’ sera.
Samples from sham-infected animals did not react.
Fertility results. There were fewer fertile females among the females caged with C.
muridarum-inoculated male mice (65%, 26/40) than among the females mated with
sham-infected males (100%, 20/20) (P 0.05) (Table 4). In addition, females mated with
C. muridarum-infected male mice produced signiﬁcantly fewer pups than control
females mated with sham-infected males (3.8 3.2/mouse versus 6.3 1.6/mouse;
P 0.05). However, when comparing the number of pups born from pregnant females,
no signiﬁcant differences were observed between the two groups (5.6 2.1 pups for
the C. muridarum-infected group versus 6.3 1.6 pups for the sham-infected group;
P 0.05). The median number of PMD when the pups were born was not different
between C. muridarum-infected females (29 PMD; range, 20 to 44 PMD) and sham-
inoculated females (26 PMD; range, 20 to 42 PMD) (P 0.05), suggesting that C.
muridarum infection did not interfere with mating.
Among the female mice shedding C. muridarum at high levels, 70% (7/10) were
infertile and delivered 2.2 3.6 pups/mouse, while in the group shedding C. muri-
darum at low levels, 26% (7/27) were infertile and delivered 4.1 2.9 pups/mouse
(P 0.05) (Fig. 3A). In the group not shedding C. muridarum, all mice (3/3, 100%) were
fertile and delivered 5.7 1.2 pups/mouse, indicating that mating had occurred.
Vertical C. muridarum infection and humoral response of newborn mice. Of the
female mice caged with C. muridarum-infected males, 65% (26/40) became pregnant,
and of these, 88% (23/26) had positive vaginal swab specimen cultures. Sixty-ﬁve
percent (17/26) of the culture-positive pregnant females transmitted C. muridarum to at
least one of their pups, while 35% (9/26) did not (Fig. 3B).
When newborn mice were euthanized at 10 postnatal days (PND), 32% (46/144) of
the pups born from C. muridarum-positive females had positive cultures of tissue
specimens from the lungs and/or intestines, 13% (19/144) had positive lung tissue
specimen cultures, and 24% (34/144) had positive intestinal tissue specimen cultures
TABLE 1 Culture results after C. muridarum genital infection in male mice
Male mouse group
No. of mice urine
positive/total no.
of mice (% positive)
No. of urine cultures
positive/total
no. of cultures (%)
Results for organ cultures at 22 PMDc
Urethra Urinary bladder
Median (range) no.
of C. muridarum IFU
No. of organs
positive/total no.
(% positive)
Median (range) no.
of C. muridarum IFU
No. of organs
positive/total no.
(% positive)
C. muridarum inoculated 10/10 (100)a 53/54 (98)a 520 (20–14,496)b 10/10 (100)a 25 (2–6,292)b 7/10 (70)a
Sham inoculated 0/5 (0) 0/30 (0) 2 0/5 (0) 2 0/5 (0)
aP 0.05 by Fisher’s exact test compared to the sham-infected male mice.
bP 0.05 by the Mann-Whitney U test compared to the sham-infected male mice.
cPMD, postmating days.
TABLE 2 C. muridarum-speciﬁc antibody ELISA titers in male, female, and newborn mice
Mouse group
IgG GMT (range) to C. muridarum EBs
Males (22 PMDa) Females (65 PMD) Newborns (10 PNDb)
C. muridarum inoculated 11,143 (6,400–12,800) 23,072 (3,200–102,400) 3,200 (1,600–6,400)
Sham inoculated 100 100 100
aPMD, postmating days.
bPND, postnatal days.
Pal et al. Infection and Immunity
July 2019 Volume 87 Issue 7 e00834-18 iai.asm.org 4
 o
n
 N
ovem
ber 27, 2019 at UNIV O
F CALIFO
RNIA IRVINE
http://iai.asm
.org/
D
ow
nloaded from
 
(Fig. 4). The median number of C. muridarum IFU was 90 (range, 20 to 91,000) from the
lungs and 48,320 (range, 200 to 180,000,000) from the intestines. All pups born from
infected dams had high anti-C. muridarum IgG titers in sera at 10 PND (GMT, 3,200;
range, 1,600 to 6,400) (Table 2). All 129 pups born from sham-infected female mice
were C. muridarum culture and C. muridarum antibody negative.
DISCUSSION
Here we describe a new mouse model of C. muridarum sexual transmission. With this
model, it is possible to characterize horizontal sexual transmission from males to
females and vertical transmission from females to their newborns. This mouse model
may help to gain a better understanding of the immunopathogenesis of sexually
transmitted chlamydial infections and to test preventative and therapeutic protocols to
control this pathogen.
To characterize horizontal transmission from males to females, male C3H/HeN mice
were inoculated in the meatus urethra with 106 C. muridarum IFU/mouse (20 times the
50% infective dose [ID50]), a dose that should result in infection of all the urethras, 80%
of the urinary bladders, 60% of the epididymides, and 20% of the testes (27). This
TABLE 3 C. muridarum-speciﬁc cell-mediated immune responses in sexually infected female mice at 56 PMDb
Male mated with
female mice
LPA response to C. muridarum
EBs (change in no. of counts
per minute, mean 1 SE)
Mean cytokine response (concn [pg/ml], mean 1 SE)
to C. muridarum EBs
IFN- IL-17 IL-4
C. muridarum inoculated 8,283 2,783a 5,578 148a 195 33a 4
Sham inoculated 562 240 15 4 4
aP 0.05 by Student’s t test compared to female mice mated with sham-inoculated male mice.
bPMD, postmating days.
FIG 2 Western blot of serum samples from C. muridarum-infected and sham-infected male, female, and
newborn mice. C. muridarum EBs were run on a 10% SDS-PAGE gel and blotted onto nitrocellulose paper.
The EBs were probed with pooled sera collected from C. muridarum- and sham-infected animals. Lane 1,
molecular weight standards. Sera from female mice: lane 2, preinfected; lane 3, at 65 postmating days
with C. muridarum-infected male mice; lane 4, at 65 postmating with control sham-infected male mice.
Sera from pups: lane 5, born from control sham-infected dams; lane 6, born from C. muridarum-infected
dams. Sera from male mice: lane 7, preinfected; lane 8, C. muridarum infected at 22 days postmating; lane
9, control sham infected at 22 days postmating. Lanes 10 and 11, monoclonal antibodies to MOMP and
the 60-kDa cysteine-rich protein of C. muridarum, respectively.
Chlamydia Sexual Transmission in Mice Infection and Immunity
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dose therefore corresponds in humans to severe C. trachomatis infections in which
males may present with epididymitis and/or orchitis (28, 29).
This mouse model bears similarities with horizontal human sexually transmitted C.
trachomatis infections. Two concordant studies reported70 to 80% transmission rates
in females from C. trachomatis-positive males (30, 31). For example, Quinn et al. (30)
studied 494 sexual partner couples using urethral and endocervical swabs for the
detection of C. trachomatis. In this study, 27 female partners of 47 infected males (57%)
were culture positive. The transmission rate increased to 70% (53/76) when nucleic acid
methods were used for diagnosis. In a study by Schillinger et al. (31), based on culture
results, 80% concordance between female and male sexual partners was found. Rank
et al. (26) infected the meatus urethra of male guinea pigs with 107 IFU of C. caviae and
caged them with naive females. In their study, 62% of the female guinea pigs shed C.
caviae. In our study, we found that 93% of female mice housed with C. muridarum-
inoculated males had at least one positive vaginal swab specimen culture over a
6-week period, and all of them had positive serological results. The higher transmission
rate observed in this study could be the result of several factors, including the high level
of susceptibility of C3H/HeN mice to C. muridarum infection, the high inoculum used to
infect males, and/or the sexual behavior of male and female mice versus that of humans
or guinea pigs.
In this model, sexually infected female mice transmitted C. muridarum to 65% of
their newborns. The rate of vertical transmission of C. trachomatis to newborns varies
depending on the perinatal care provided. For example, in sub-Saharan Africa and Asia,
where women receive no or little perinatal care, it was reported that 33 to 60% of
newborns from C. trachomatis-infected mothers were culture positive, a rate similar to
that found in this study (12, 15, 32, 33). Schachter et al. (12) did a prospective study of
TABLE 4 Fertility results
Male mated with
female mice
Results for all female mice Results for all pregnant mice
No. of pregnant mice/
total no. of mice (%)
Mean 1 SD no. of
pups born/mouse
Median (range) PMDc
when pups were born
Mean 1 SD no. of pups
born/pregnant mouse
C. muridarum inoculated 26/40 (65)a 3.8 3.2b 29 (20–44) 5.6 2.1
Sham inoculated 20/20 (100) 6.3 1.6 26 (20–42) 6.3 1.6
aP 0.05 by Fisher’s exact test compared to the female mice mated with sham-inoculated male mice.
bP 0.05 by Student’s t test compared to the female mice mated with sham-inoculated male mice.
cPMD, postmating days.
FIG 3 (A) Relationship between vaginal shedding and fertility outcome. The numbers on the bars
indicate the percentages of mice that were infertile. *, P 0.05. (B) Correlation between sexually C.
muridarum-infected pregnant female mice and transmission of the infection to their pups. The numbers
on the bars indicate the percentages of pregnant mice that were culture positive. *, P 0.05.
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perinatal transmission with a group of 5,531 pregnant women in San Francisco, CA, for
a 5-year period. Of these patients, 262 (4.7%) had positive C. trachomatis cervical swab
specimen cultures and 131 of their infants were followed. C. trachomatis was cultured
from 36% (47/131) of the infants, and 60% (79/131) of the infants had a positive
serology. Positive C. trachomatis cultures of swab specimens from the eyes, lungs,
rectum, and vagina from the newborns were obtained. These vertical transmission rates
are similar to those reported in this study. We did not collect ocular swab specimen
cultures because C. muridarum does not effectively infect the eyes of mice (34).
Here we found that a primary C. muridarum infection resulted in decreased fertility.
Different factors in males, females, and fetuses may have contributed to the decreased
fertility. Acute C. trachomatis infection in men may cause epididymitis, which affects
sperm production, functionality, and/or transport blockage, leading to a temporary
decrease in fertility (32, 35, 36). C. trachomatis infections in pregnant females have been
associated with low birth weight, premature birth, premature rupture of membranes,
and an increased risk of fetal death (15, 32, 37, 38). C. muridarum can also produce fetal
damage during pregnancy (35). Scarring of the fallopian tube can lead to ectopic
pregnancy and infertility (25, 32, 39, 40). In this study, one C. muridarum-infected female
delivered 5 pups at 20 PMD. Interestingly, at 65 PMD, bilateral hydrosalpinx formation
was observed. Therefore, further studies are needed to delineate the exact causes and
mechanisms of infertility in this mouse model of sexual transmission.
In most studies, to increase susceptibility to a C. trachomatis or a C. muridarum
infection, female mice are pretreated with medroxyprogesterone (41). Progesterone
treatment pauses the estrous cycle at diestrus and induces a shift toward Th2 immune
responses (42–45). Since C. trachomatis and C. muridarum infections are mainly con-
trolled by Th1 immune responses, switching to a Th2 response makes women and
female mice more susceptible to infection and PID (41, 46, 47). The mouse model
presented here does not require hormonal pretreatment to increase susceptibility to C.
muridarum infection and therefore more closely parallels the situation in humans.
Recently, Zhang et al. (48) showed that vaginally inoculated mice disseminated C.
muridarum into the gastrointestinal tract within a week of the infection and suggested
that Chlamydia might be using the alimentary canal as a reservoir. Igietseme et al. (34)
also reported that C. muridarum infection of several mucosal sites, including the genital
tract, leads to colonization of the large intestine for at least 8 months. Since the goal of
FIG 4 Percentage of newborn mice with positive organ specimen cultures born from C. muridarum-
infected dams. Each circle represents a single mouse. The horizontal line indicates the median number
of C. muridarum IFU recovered from the lungs and/or intestines.
Chlamydia Sexual Transmission in Mice Infection and Immunity
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this study was to establish a vertical and horizontal sexual transmission model, we did
not collect rectal swab specimens, and therefore, we cannot exclude the possibility that
coprophagia or grooming resulted in infection of the gastrointestinal tract. However, in
a group of sexually infected female mice, we cultured the stools at 65 PMD (data not
shown). At that point, the stools of 92% (11/12) of sexually infected mice were C.
muridarum positive, suggesting that C. muridarum had also disseminated to the gas-
trointestinal tract in this sexual infection model. Further studies are needed to conﬁrm
these results and determine the role of gastrointestinal colonization in the pathogen-
esis of chlamydial infections.
A potential limitation of this study is that outcome events were characterized only
during a primary infection. A primary C. trachomatis infection in humans can lead to
severe bilateral pyosalpinx with tubal dilatation and, therefore, long-term sequelae,
including infertility (49). This is not surprising since, due to the lack of adaptive
immunity, primary infections are usually more severe than reinfections (50). In addition,
young females, the population more likely to have a primary infection, frequently have
cervical ectopy, which makes them more susceptible to C. trachomatis infection (51, 52).
Young female mice are also more susceptible to C. muridarum infection and infertility
than older animals (53). Likewise, most cases of PID occur within 2 weeks of the
diagnosis of an acute C. trachomatis infection (54). In the landmark study by Westrom
et al. (9), the majority of the infertility cases (56%, 79/141) occurred in women following
a single PID episode. Although there is a lack of long-term studies, this evidence
suggests that most cases of infertility are due to a severe primary C. trachomatis
infection. Furthermore, it is important to emphasize that only half of the C. trachomatis
genital infections in women spontaneously resolve in 1 year (55). Thus, as in the
model described here, a woman can simultaneously become pregnant and infected
with C. trachomatis and remain infected until delivery. Hence, this model may help
characterize severe primary C. trachomatis infections during pregnancy.
Another limitation of this study is the use of a high C. muridarum dose to infect the
male mice (27). In humans, only a small percentage of males infected with C. tracho-
matis have involvement of the upper genitourinary system (56). However, males with
severe C. trachomatis infections likely cause severe infections and pathological damage
to their sexual partners by transmitting a high bacterial load. Here, female mice with
high levels of C. muridarum vaginal shedding had lower fertility rates and transmitted
the infection to more newborns than female mice with low levels of shedding. Future
studies using a low C. muridarum dose may help answer these questions.
In conclusion, we implemented the ﬁrst mouse model of horizontal and vertical
chlamydial sexual transmission. This mouse model could serve to characterize the
immunopathogenesis of chlamydial infections in sexual partners and their offspring. In
addition, it could be used to test therapeutic and preventative measures for females,
males, and newborns.
MATERIALS AND METHODS
C. muridarum stocks. C. muridarum strain NiggII (previously called C. trachomatis mouse pneumo-
nitis biovar) was grown in HeLa-229 cells using Eagle’s minimal essential medium supplemented with 5%
fetal calf serum and cycloheximide (1 g/ml) (57, 58). Elementary bodies (EBs) were puriﬁed as described
previously and stored in sugar phosphate glutamate buffer (SPG) at 80°C (21, 58). The number of C.
muridarum inclusion-forming units (IFU) was determined in HeLa-229 cells (59).
Sexual infection. Eight-week-old male and female C3H/HeN (H-2k haplotype) mice were purchased
from Charles River Laboratories. The mice were maintained in the vivarium at the University of California,
Irvine (UCI), and all experiments were carried out in accordance with NIH and UCI IACUC guidelines. Male
mice were infected in the meatus urethra with 106 C. muridarum inclusion-forming units (IFU; 20 times
the ID50) in 2 l of SPG (27). Sham-infected mice received only SPG. At 1 day after infection, each male
mouse was housed with four naive females for 3 weeks. The mice were housed in vented, ﬁltered cages
with 0.25-in.-thick corncob bedding (Envigo, Somerset, NJ). The beddings were changed every 2 weeks
and also when performing spot checks, if necessary. Urine from male mice was collected twice a week
for 3 weeks. Male mice were held over a clean plastic sheet (Paraﬁlm M; Bemis Inc., Neenah, WI) and
allowed to spontaneously urinate. The urine was collected with a sterile pipette and mixed with an equal
volume of SPG. Urine samples were inoculated into HeLa-229 cell monolayers grown in 48-well plates.
Male mice were euthanized at 3 weeks postmating, while female mice were euthanized at 9 weeks
postmating. Newborns were euthanized at 10 PND (60). The experiment was repeated.
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Immunoassays. Blood was collected from mice on the day before infection and following eutha-
nasia: serum from male mice was collected at 22 PMD, from female mice at 65 PMD, and from newborn
mice at 10 PND. C. muridarum-speciﬁc antibody titers in serum were determined by an enzyme-linked
immunosorbent assay (ELISA) as described previously (59). In brief, 96-well plates were coated with C.
muridarum EBs, and serum was added to each well in 2-fold serial dilutions. After incubation, the serum
was discarded, the wells were washed, and the plates were incubated with horseradish peroxidase-
conjugated goat anti-mouse IgG antibodies (Cappel antibodies; ICN). The binding was measured in an
enzyme immunoassay reader (Labsystems Multiskan, Helsinki, Finland). Preinfection sera were used as
negative controls. The geometric mean titers (GMT) were expressed as the reciprocal of the dilution (59).
Western blotting was performed with C. muridarum EBs as published previously (59, 61). In short,
following transfer to a nitrocellulose membrane, the nonspeciﬁc binding sites were blocked. Serum
samples at a 1:100 dilution were incubated overnight. The membrane was washed and incubated with
horseradish peroxidase-conjugated goat anti-mouse Ig antibody, followed by visualization of the bands
by development with hydrogen peroxide and 4-chloro-1-naphthol.
A T-cell lymphoproliferative assay (LPA) was performed as described previously (59). Brieﬂy, spleens
from mice were collected and enriched for T cells by passage over a nylon wool column. Enriched T cells
(95% pure) were counted, and 105 cells/well were aliquoted. Antigen-presenting cells (APC) were
prepared by irradiating splenocytes with 3,300 rads. UV-inactivated C. muridarum EBs were added at a
concentration of 5 EBs to 1 APC. Negative-control wells received medium alone, and concanavalin A
(5 g/ml) was used as a positive control. Cell proliferation was measured by addition of 1 Ci of
[methyl-3H]thymidine per well. The mean count was determined from triplicate cultures. The change in
the number of counts per minute was calculated by subtracting the number of counts per minute
obtained from T cells stimulated with medium from the number of counts per minute measured from
T cells stimulated with C. muridarum EBs.
The levels of IFN-, IL-4, and IL-17 in supernatants from splenic T cells stimulated as described above
were determined using commercial kits (BD Biosciences, San Diego, CA) (62).
Evaluation of C. muridarum infection. To monitor infection in male mice, urine was collected twice
a week for 3 weeks (limit of detection [LOD], 20 C. muridarum IFU/ml of urine). At the end of mating, male
mice were euthanized and the urethra and urinary bladder were cultured (LOD, 10 C. muridarum
IFU/organ). To monitor sexual transmission to female mice, vaginal swab specimens were collected twice
a week for 4 weeks and then once a week for three additional weeks (LOD, 2 C. muridarum IFU/swab).
Newborn mice were nursed by their mothers for 10 days and euthanized, and their lungs and small and
large intestines were collected, homogenized, and cultured (LOD, 20 C. muridarum IFU/organ) (63). Urine,
vaginal swab specimens, and tissue homogenates were cultured in HeLa-229 cell monolayers, and IFU
were stained with monoclonal antibody MoPn-40, which recognizes the major outer membrane protein
of C. muridarum (62).
Statistical analyses. For statistical analyses, the Mann-Whitney U test was used to compare the
number of C. muridarum IFU, Student’s t test was used to compare the immune responses and the
number of pups, and Fisher’s exact test was used to analyze 2-by-2 contingency tables. A P value of
0.05 was considered signiﬁcant.
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